Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Ovarian Cancer Market Grown from 2024 to 2025?
In the last few years, the size of the ovarian cancer market has witnessed a significant surge. Its growth trajectory indicates a leap from $3.67 billion in 2024 to $4.36 billion in 2025, translating to a compound annual growth rate (CAGR) of 18.9%. Factors boosting the growth during the historical period include an uptick in the elderly population, an escalating number of ovarian cancer incidences, higher ovarian cancer prevalence, increased government-led initiatives, and enhanced healthcare expenditure.
What Growth Rate Is Anticipated for the Ovarian Cancer Market in the Coming Years?
The forecast for the ovarian cancer market indicates significant expansion in the coming years, with predictions reaching $8.61 billion in 2029, at a compound annual growth rate (CAGR) of 18.5%. This expected upturn during the forecast period is driven by factors such as intensified research into targeted treatment and precision medicine, an aging population, enhanced health awareness, increasing instances of ovarian cancer, and growing healthcare spending. Known trends contributing to this period include the development of novel therapies, progress in radiation treatment, sophistication of healthcare infrastructure, tech advances, and the introduction and acceptance of new pharmaceuticals.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21240&type=smp
Who Are the Leading Companies in the Ovarian Cancer Market?
Major companies operating in the ovarian cancer market are Pfizer Incorporated, Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Novogen Limited, Oasmia Pharmaceutical AB, Clovis Oncology Inc., Aeterna Zentaris Inc., Allarity Therapeutics Inc., Ellipses Pharma Ltd.
What Are the Key Drivers of the Ovarian Cancer Market?
The rise in the number of females is projected to fuel the ovarian cancer market’s expansion. This includes all women residing in a certain region or globally at a given moment. The augmentation in the female populace is attributed to factors like higher life expectancy, enhanced healthcare, and demographic transitions. Treatments for ovarian cancer, including surgical procedures, chemotherapy, targeted therapy, and immunotherapy, can eradicate cancerous cells, decelerate disease advancement, relieve symptoms, and boost survival rates. This ultimately ameliorates the quality of life and offers hope for improved long-term results. For instance, as per the Census Bureau, a US governmental organization, stated in March 2024 that the US had an approximate female populace of 168 million in July 2022. Additionally, females aged 85 and above were approximately 1.9 million more. Moreover, in December 2022 according to a report by CEIC Data, a finance service firm based in the UK, revealed that the count of females aged between 15 and 64 was 2,951,856 in 2022, indicating a surge from 2,940,645 in 2021. For these reasons, the ascending number of females is contributing to the ovarian cancer market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21240&type=smp
What Are the Key Market Segments in the Ovarian Cancer Industry?
The ovarian cancer market covered in this report is segmented –
1) By Type: Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, Primary Peritoneal Carcinoma
2) By Treatment: Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, Surgery
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By End-user: Hospitals, Diagnostic Centers, Drug Stores, Online Pharmacies, Other End Users
Subsegments:
1) By Epithelial Ovarian Tumors: Serous Carcinoma, Mucinous Carcinoma, Endometrioid Carcinoma, Clear Cell Carcinoma, Brenner Tumors
2) By Ovarian Germ Cell Tumors: Dysgerminoma, Teratoma, Yolk Sac Tumor, Embryonal Carcinoma, Choriocarcinoma
3) By Ovarian Stromal Tumors: Granulosa Cell Tumors, Thecomas, Sertoli-Leydig Cell Tumors
4) By Primary Peritoneal Carcinoma: High-Grade Serous Carcinoma, Low-Grade Serous Carcinoma
What Are the Latest Trends in the Ovarian Cancer Market?
Prominent businesses that are part of the ovarian cancer market are shifting their focus towards innovative solutions, such as Artificial Intelligence (AI) platforms, to scrutinize complicated medical data with precision. In the realm of ovarian cancer, an AI platform functions as a tech-centric system employing AI and Machine Learning (ML) to augment various sectors of ovarian cancer care. These platforms generally harmonize medical imaging, genomic data, Electronic Health Records (EHRs), and real-time analytics to back early detection, diagnosis, individualized treatment plans, and patient monitoring. For instance, AIIMS Delhi, along with CDAC Pune, launched iOncology.ai, a domestically developed AI platform in February 2024. This platform is designed to detect breast and ovarian cancer at an early stage and relies on deep learning models to scrutinize radiological and histopathological images accurately, aiming to enhance early diagnoses and survival ratios. Currently functional in numerous hospitals, iOncology.ai collaborates with the healthcare system to offer risk evaluations and suggest mammograms, especially for women in rural territories. It is part of a more extensive initiative to incorporate AI into healthcare and minimize the strain on medical systems.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-global-market-report
What Are the Key Regional Markets in the Ovarian Cancer Industry?
North America was the largest region in the ovarian cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovarian cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21240
This Report Delivers Insight On:
1. How big is the ovarian cancer market, and how is it changing globally?
2. Who are the major companies in the ovarian cancer market, and how are they performing?
3. What are the key opportunities and risks in the ovarian cancer market right now?
4. Which products or customer segments are growing the most in the ovarian cancer market?
5. What factors are helping or slowing down the growth of the ovarian cancer market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model